Implementation of precision medicine in healthcare—A European perspective
A Stenzinger, EK Moltzen, E Winkler… - Journal of Internal …, 2023 - Wiley Online Library
The technical development of high‐throughput sequencing technologies and the parallel
development of targeted therapies in the last decade have enabled a transition from …
development of targeted therapies in the last decade have enabled a transition from …
Compressive stresses in cancer: characterization and implications for tumour progression and treatment
JA Linke, LL Munn, RK Jain - Nature Reviews Cancer, 2024 - nature.com
Beyond their many well-established biological aberrations, solid tumours create an
abnormal physical microenvironment that fuels cancer progression and confers treatment …
abnormal physical microenvironment that fuels cancer progression and confers treatment …
Precise treatment of pancreatic ductal adenocarcinoma
H Ren - Cancer Letters, 2024 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a highly heterogeneous tumor comprising
pancreatic cancer cells, fibroblasts, immune cells, vascular epithelial cells, and other cells in …
pancreatic cancer cells, fibroblasts, immune cells, vascular epithelial cells, and other cells in …
Research progress on the immune microenvironment and immunotherapy in gastric cancer
P Mou, Q Ge, R Sheng, T Zhu, Y Liu… - Frontiers in Immunology, 2023 - frontiersin.org
The tumor microenvironment, particularly the immune microenvironment, plays an
indispensable role in the malignant progression and metastasis of gastric cancer (GC). As …
indispensable role in the malignant progression and metastasis of gastric cancer (GC). As …
Hyaluronic acid metabolism and chemotherapy resistance: recent advances and therapeutic potential
Hyaluronic acid (HA) is a major component of the extracellular matrix, providing essential
mechanical scaffolding for cells and, at the same time, mediating essential biochemical …
mechanical scaffolding for cells and, at the same time, mediating essential biochemical …
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pancreatic cancer is a major cause of cancer-related death, but despondently, the outlook
and prognosis for this resistant type of tumor have remained grim for a long time. Currently, it …
and prognosis for this resistant type of tumor have remained grim for a long time. Currently, it …
Breaking the stromal barrier in pancreatic cancer: Advances and challenges
M Chakkera, JB Foote, B Farran… - Biochimica et Biophysica …, 2023 - Elsevier
Pancreatic cancer (PC) remains a leading cause of mortality worldwide due to the absence
of early detection methods and the low success rates of traditional therapeutic strategies …
of early detection methods and the low success rates of traditional therapeutic strategies …
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
Despite the efforts, pancreatic ductal adenocarcinoma (PDAC) is still highly lethal.
Therapeutic challenges reside in late diagnosis and establishment of peculiar tumor …
Therapeutic challenges reside in late diagnosis and establishment of peculiar tumor …
Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is characterized by a highly
desmoplastic and extreme immunosuppressive tumor microenvironment (TME), which …
desmoplastic and extreme immunosuppressive tumor microenvironment (TME), which …
[HTML][HTML] Deciphering Drug Resistance: Investigating the Emerging Role of Hyaluronan Metabolism and Signaling and Tumor Extracellular Matrix in Cancer …
DL Vitale, A Parnigoni, M Viola, E Karousou… - International Journal of …, 2024 - mdpi.com
Hyaluronan (HA) has gained significant attention in cancer research for its role in
modulating chemoresistance. This review aims to elucidate the mechanisms by which HA …
modulating chemoresistance. This review aims to elucidate the mechanisms by which HA …